Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia

Metabolism: Clinical and Experimental

Volumn 50, Issue 6, 2001, Pages 635-639

  Frenais R ^a   Maugeais, C ^a   Ouguerram, K ^a   Zair Y ^a   Bard, J M ^a   Charbonnel, B ^a   Magot, T ^a   Krempf, M ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DOWN REGULATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HUMAN; KINETICS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SYNTHESIS; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034966472     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.23285     Document Type: Article

References (30)

1. Apo B metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm
2. Lipoprotein metabolism in familial hypercholesterolemia
3. Apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia: A stable isotope study
4. In vivo metabolism of apolipoprotein AI in a patient with homozygous familial hypercholesterolemia
5. Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein AI mRNA in Hep G2 cells
6. Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B100
7. Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption
8. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia
9. LDL apheresis using the Liposorber LA-15 system in coronary and peripheral vascular disease associated with severe hypercholesterolemia
10. Lipoprotein particles in homozygous familial hypercholesterolemia patients treated with portacaval shunt and LDL apheresis
11. Extracorporeal treatment of hypercholesterolemia
12. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
13. Blood volume measurement: A critical study. Prediction of normal values, controlled measurement of sequential changes, choice of a bedside method
14. Human apolipoprotein AI and AII metabolism
15. A simple and rapid method for preparation of apolipoproteins for electrophoresis
16. Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data
17. Evaluation of apo AI kinetics in human using simultaneous endogenous stable isotope and exogenous radiotracer methods
18. Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolemia: A possible activation of the reverse cholesterol transport system
19. Changes in lipoprotein (a), LDL-cholesterol and apolipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL-apheresis
20. Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresis
21. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein AI and B100 kinetics
22. Delayed catabolism of high density lipoprotein AI and AII in human cholesteryl ester transfer protein deficiency
23. Efficacité biologique des LDL-aphérèses dans les hypercholestérolémies majeures
24. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia
25. High density lipoprotein apolipoprotein AI kinetics in NIDDM: A stable isotope study
26. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor
27. A lipid hypothesis: Prediction, observation and the triglyceride/HDL gap
28. Plasma high density lipoprotein is increased in man when low density lipoprotein (LDL) is lowered by LDL-pheresis
29. Expression cloning of SR-BI, a CD36-related class B scavenger receptor
30. Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells